Skip to content
healthcare.dev

Cisatracurium besylate

NDC 70436-113, Cisatracurium besylate, injection, from Slate Run Pharmaceuticals, LLC.

Product NDC
70436-113
Status
Listed
Labeler
Slate Run Pharmaceuticals, LLC
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA216538
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70436-113 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CISATRACURIUM BESYLATE2 mg/mL

Pharmacologic classes

Neuromuscular Nondepolarizing Blockade [PE]; Nondepolarizing Neuromuscular Blocker [EPC]

Package NDCNDC-11Package
70436-113-827043601138210 VIAL, SINGLE-DOSE in 1 CARTON (70436-113-82) / 10 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e06c4d57-bfc7-45ad-b1cd-b5b88dc43b50

Use it

Look up 70436-113 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70436-113 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70436-113. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.